The Supreme Court has rejected a lawsuit claiming that Bayer's Roundup weedkiller caused cancer, a decision with far-reaching consequences for thousands of similar cases pending against the chemical manufacturer.
The ruling stands to reshape the legal landscape surrounding product liability claims tied to the herbicide. Bayer faces an enormous backlog of litigation from plaintiffs alleging that exposure to Roundup resulted in various cancers, and this Supreme Court action could significantly curtail the viability of those claims moving forward.
The specific grounds and reasoning behind the court's rejection will likely become a roadmap for how lower courts handle the remaining cases in the pipeline. Legal experts anticipate the decision will have a cascading effect on settlement negotiations and future filings related to Roundup exposure.
Bayer acquired the Roundup product line through its purchase of Monsanto and has been defending itself against mounting litigation over the past several years. The company has consistently disputed claims that the herbicide causes cancer, while some studies and settlements have suggested otherwise.
The Supreme Court's action removes at least one major challenge from Bayer's docket, but the company still faces considerable legal exposure from the broader category of similar suits. How other courts interpret and apply this ruling will determine whether the litigation wave subsides or continues to gain momentum.
Author Sarah Mitchell: "This decision gives Bayer breathing room, but it doesn't resolve the fundamental question of whether Roundup is actually dangerous, and that matters for the thousands of people who say they got sick."
Comments